24-hour Urinary Hormone
While menopause is not a disease, it is an expression of the continuum of a woman’s
life cycle. The cessation of ovarian function
and the resulting decline in estrogen levels
are usually accompanied by hot flashes, loss of bone density, osteoporosis as well as an increased risk for heart disease. Decreasing levels of testosterone in middle-aged men have been associated with loss of libido, impotence, depression, loss of muscle tone and obesity. Identification of hormonal status is important in the treatment of menopausal or peri-menopausal symptoms as well as evaluation for those currently taking hormonal replacement. For women experiencing facial hair, ovarian cysts, loss of libido and PMS or other symptoms occurring before menses, identification of hormonal imbalances would be needed to develop an appropriate treatment plan.
NeuroAdrenal Profile and NeuroSleep Profile
Neurotransmitters are chemical messengers that relay signals between nerve cells and play an important role our day-to-day lives.
Some are excitatory and provide
the body with energy for concentration, muti-tasking, memory, and a healthy metabolism. Others are inhibitory and enable the nervous system to “pace it’s self,” focus, bounce back from stress as well as sleep. Imbalances in these neurotransmitters can result in a constellation of symptoms ranging from anxiety, irritability, agitation, tension and panic attacks to fatigue, lack of energy, difficulty concentrating, focusing or remembering. Imbalances can also play a role in insomnia and sleep disturbances as well as poor response to stress. The evaluation of neurotransmitters finds and measures the real and physical problem associated with many emotional states.
Comprehensive Nutritional Panel
This is a clinically effective diagnostic tool for the prevention and management
of chronic disease conditions like cancer,
diabetes, osteoporosis, heart disease
as well as chronic fatigue and fibromyalgia. Overwhelming clinical evidence confirms that nutrient deficiencies have been shown to suppress immune function contributing to chronic disease process including cardiovascular disease, diabetes, arthritis and Alzheimer's.
Lipoprotein Particle Profile (LPP)
Not all cholesterol is the same. The “good” cholesterol is highly dense with protein and low in fat (high density lipoprotein or and HDL) the “bad” cholesterol has a lower density of protein and a higher fat content (low density lipoprotein or LDL). More important than the difference between LDL and HDL is the fact that there are different types of LDL particles and some are much more dangerous than others. The LPP directly measures both the size and number of several classes of lipoprotein particles, including critical risk factors as cited by the National Cholesterol Education Program, giving an accurate assessment of cardiovascular risk. For example, the LPP test measures RLP (remnant lipoprotein) and Lp(a), both very atherogenic, but with very different effective treatment options. A standard cholesterol test does not measure these types of LDL. Moreover, since it is the actual lipoproteins (not the cholesterol inside them) that contribute to cardiovascular disease, the LPP is more advanced than standard cholesterol testing. The LPP measures the lipoprotein particles directly, giving a precise evaluation of their size and density. Armed with this information, a clinician is empowered to make the best possible decisions regarding their patients’ care when it comes to reducing cardiovascular risk.
Comprehensive Digestive Stool Analysis
The digestion of food, assimilation of nutrients, and timely elimination of waste are the cornerstones of good health. Poor digestion and malabsorption of vital
nutrients can contribute to degenerative diseases, compromised immune status and nutritional deficiencies. Additionally, low gastric acids, chronic maldigestion, food allergens impact on bowel absorptive surfaces, bacterial overgrowth, pathogenic bacteria, yeast and parasites can impair the gastric barrier leading to “leaky gut syndrome.” This test provides a non-invasive assessment of gastric dysfunction as well as bacterial overgrowth or imbalances, yeast, parasites and related toxic irritants. It also provides the biomarkers needed to distinguish between inflammatory bowel disease (IBD) and the less serious inflammatory bowel syndrome (IBS), all leading to appropriate treatment.
Urine Toxic Metals and Fecal Toxic Metals
According to current research, people with dental amalgams have approximately 10 times higher body concentrations of mercury than people who do not
have mercury amalgams, and when measured in laboratory test the mercury levels highly correlate with the number of amalgams in the mouth. But mercury is not the only toxic metal accumulated in the body from environmental exposure – arsenic, beryllium, cadmium, lead, thallium and uranium – all can be associated with an array of chronic disease and poor health. The evaluation of the accumulation of toxic metals is necessary for the diagnosis and treatment of many conditions.
Yeast Culture and Sensitivity
Infection with yeast can cause a variety
of symptoms both inside and outside
the gastrointestinal track. In addition,
short-term and long-term
uses of antibiotics have contributed to yeast infections with both gastrointestinal and vaginal symptoms as well as chronic fatigue syndrome, dermatitis and other conditions. Identification of abnormal levels of specific yeast species is an important diagnostic step in creating an appropriate treatment plan.
|